• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常和患病鼻窦黏膜中表面活性物质层状体的存在情况。

Presence of surfactant lamellar bodies in normal and diseased sinus mucosa.

作者信息

Woodworth Bradford A, Smythe Nancy, Spicer Samuel S, Schulte Bradley A, Schlosser Rodney J

机构信息

Department of Otolaryngology, Head and Neck Surgery, Medical University of South Carolina, Charleston, SC 29425, USA.

出版信息

ORL J Otorhinolaryngol Relat Spec. 2005;67(4):199-202. doi: 10.1159/000087093. Epub 2005 Jul 15.

DOI:10.1159/000087093
PMID:16024936
Abstract

BACKGROUND

Pulmonary surfactant originates from phospholipid lamellar bodies secreted from the type II epithelial cell of the alveolus. In the lower airway, surfactant optimizes surface tension and oxygen exchange, decreases mucus viscosity and aids in mechanical elimination of inhaled pathogens. In addition to the lung, lamellar bodies have been identified in many other cell types throughout the human body. However, no prior studies have identified lamellar bodies in human sinus mucosa.

OBJECTIVES

We performed ultrastructural studies to assess whether lamellar bodies are present in the human sinus in a variety of diseased and normal epithelium.

METHODS

We biopsied sinus mucosa from 5 subjects, 1 each with allergic fungal sinusitis, eosinophilic mucin rhinosinusitis, cystic fibrosis, frontal sinus mucocele, and cerebrospinal fluid leak (healthy control). Mouse lung served as a positive control. Specimens were prepared using ferrocyanide-reduced osmium tetroxide and thiocarbohydrazide for fixation (R-OTO method) to avoid extraction of phospholipids during dehydration and were viewed with transmission electron microscopy.

RESULTS

We identified lamellar bodies in the sinus mucosa of all patients. Additionally, preservation of mouse lung lamellar bodies confirms that the R-OTO method is a valid technique to preserve these structures.

CONCLUSIONS

We describe a simpler, faster technique for identification of cellular phospholipid components than those used previously. Definitive identification of these lamellar bodies within ciliated pseudostratified epithelium of the upper airway indicates that surfactant may have a role in sinus function and pathophysiology.

摘要

背景

肺表面活性物质起源于肺泡II型上皮细胞分泌的磷脂板层小体。在下呼吸道,表面活性物质可优化表面张力和氧气交换,降低黏液黏度,并有助于机械性清除吸入的病原体。除了肺,板层小体还在人体许多其他细胞类型中被发现。然而,此前尚无研究在人鼻窦黏膜中发现板层小体。

目的

我们进行了超微结构研究,以评估在各种患病和正常上皮组织的人鼻窦中是否存在板层小体。

方法

我们从5名受试者身上获取鼻窦黏膜活检样本,其中1名患有变应性真菌性鼻窦炎,1名患有嗜酸性黏液性鼻-鼻窦炎,1名患有囊性纤维化,1名患有额窦黏液囊肿,1名作为健康对照(脑脊液漏患者)。小鼠肺作为阳性对照。使用亚铁氰化物还原四氧化锇和硫代碳酰肼进行样本固定(R-OTO法),以避免脱水过程中磷脂的提取,然后用透射电子显微镜观察。

结果

我们在所有患者的鼻窦黏膜中均发现了板层小体。此外,小鼠肺板层小体的保存情况证实R-OTO法是保存这些结构的有效技术。

结论

我们描述了一种比以往使用的方法更简单、更快的鉴定细胞磷脂成分的技术。在上呼吸道纤毛假复层上皮内明确鉴定出这些板层小体,表明表面活性物质可能在鼻窦功能和病理生理学中发挥作用。

相似文献

1
Presence of surfactant lamellar bodies in normal and diseased sinus mucosa.正常和患病鼻窦黏膜中表面活性物质层状体的存在情况。
ORL J Otorhinolaryngol Relat Spec. 2005;67(4):199-202. doi: 10.1159/000087093. Epub 2005 Jul 15.
2
'Eosinophilic fungal rhinosinusitis': a common disorder in Europe?“嗜酸性粒细胞性真菌性鼻-鼻窦炎”:在欧洲是一种常见疾病吗?
Laryngoscope. 2003 Feb;113(2):264-9. doi: 10.1097/00005537-200302000-00013.
3
Evaluation of ultrastructural changes in paranasal sinus mucosa after functional endoscopic sinus surgery in patients with chronic rhinosinusitis.慢性鼻窦炎患者功能性鼻内镜鼻窦手术后鼻旁窦黏膜超微结构变化的评估
Am J Rhinol. 2001 Jul-Aug;15(4):225-9.
4
The cytology and microbiology of persistent paranasal sinus secretions after endoscopic sinus surgery: a controlled study.内镜鼻窦手术后持续性鼻窦分泌物的细胞学和微生物学:一项对照研究。
Laryngoscope. 2007 Nov;117(11):2041-4. doi: 10.1097/MLG.0b013e3181379d96.
5
Increased expression of interleukin-9, interleukin-9 receptor, and the calcium-activated chloride channel hCLCA1 in the upper airways of patients with cystic fibrosis.白细胞介素-9、白细胞介素-9受体及钙激活氯离子通道hCLCA1在囊性纤维化患者上呼吸道中的表达增加。
Laryngoscope. 2003 Jun;113(6):1037-42. doi: 10.1097/00005537-200306000-00022.
6
Surfactant protein A and D in human sinus mucosa: a preliminary report.人鼻窦黏膜中的表面活性蛋白A和D:初步报告。
ORL J Otorhinolaryngol Relat Spec. 2007;69(1):57-60. doi: 10.1159/000096718. Epub 2006 Nov 2.
7
Surfactant-like lamellar bodies in the mucosa of the human nose.人鼻黏膜中类似表面活性剂的板层小体。
Acta Otolaryngol. 1990 Mar-Apr;109(3-4):307-13. doi: 10.3109/00016489009107447.
8
Upregulation of surfactant protein A in chronic rhinosinusitis.慢性鼻-鼻窦炎中表面活性蛋白A的上调
Laryngoscope. 2006 Feb;116(2):328-30. doi: 10.1097/01.mlg.0000194223.22763.5f.
9
Antigen-specific IgE in sinus mucosa of allergic fungal rhinosinusitis patients.变应性真菌性鼻-鼻窦炎患者鼻窦黏膜中的抗原特异性IgE
Am J Rhinol. 2008 Sep-Oct;22(5):451-6. doi: 10.2500/ajr.2008.22.3227.
10
Surfactant and its role in chronic sinusitis.表面活性剂及其在慢性鼻窦炎中的作用。
Ann Otol Rhinol Laryngol Suppl. 2006 Sep;196:40-4. doi: 10.1177/00034894061150s907.

引用本文的文献

1
The Therapeutic Potential of Myo-Inositol in Managing Patients with Respiratory Diseases.肌醇在呼吸系统疾病患者管理中的治疗潜力。
Int J Mol Sci. 2025 Feb 28;26(5):2185. doi: 10.3390/ijms26052185.
2
Surfactant protein a expression in chronic rhinosinusitis and atrophic rhinitis.表面活性蛋白a在慢性鼻窦炎和萎缩性鼻炎中的表达
Int Arch Otorhinolaryngol. 2015 Apr;19(2):130-4. doi: 10.1055/s-0035-1546432. Epub 2015 Feb 20.
3
Treatment-recalcitrant chronic rhinosinusitis with polyps is associated with altered epithelial cell expression of interleukin-33.
治疗抵抗性慢性鼻-鼻窦炎伴鼻息肉与白细胞介素-33 上皮细胞表达改变有关。
Am J Rhinol Allergy. 2010 Mar-Apr;24(2):105-9. doi: 10.2500/ajra.2010.24.3446.
4
Lipids including cholesteryl linoleate and cholesteryl arachidonate contribute to the inherent antibacterial activity of human nasal fluid.包括亚油酰胆固醇酯和花生四烯酰胆固醇酯在内的脂质有助于人类鼻腔分泌物固有的抗菌活性。
J Immunol. 2008 Sep 15;181(6):4177-87. doi: 10.4049/jimmunol.181.6.4177.